BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27210243)

  • 1. Fatty change in moderately and poorly differentiated hepatocellular carcinoma on MRI: a possible mechanism related to decreased arterial flow.
    Asayama Y; Nishie A; Ishigami K; Ushijima Y; Takayama Y; Okamoto D; Fujita N; Kubo Y; Aishima S; Yoshizumi T; Honda H
    Clin Radiol; 2016 Dec; 71(12):1277-1283. PubMed ID: 27210243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apparent diffusion coefficient of hepatocellular carcinoma on diffusion-weighted imaging: Histopathologic tumor grade versus arterial vascularity during dynamic magnetic resonance imaging.
    Park IK; Yu JS; Cho ES; Kim JH; Chung JJ
    PLoS One; 2018; 13(5):e0197070. PubMed ID: 29750794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poorly versus moderately differentiated hepatocellular carcinoma: vascularity assessment by computed tomographic hepatic angiography in correlation with histologically counted number of unpaired arteries.
    Asayama Y; Yoshimitsu K; Irie H; Nishihara Y; Aishima S; Tajima T; Hirakawa M; Ishigami K; Kakihara D; Taketomi A; Honda H
    J Comput Assist Tomogr; 2007; 31(2):188-92. PubMed ID: 17414751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI proton density fat fraction for estimation of tumor grade in steatotic hepatocellular carcinoma.
    Kupczyk PA; Kurt D; Endler C; Luetkens JA; Kukuk GM; Fronhoffs F; Fischer HP; Attenberger UI; Pieper CC
    Eur Radiol; 2023 Dec; 33(12):8974-8985. PubMed ID: 37368108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial blood supply of hepatocellular carcinoma and histologic grading: radiologic-pathologic correlation.
    Asayama Y; Yoshimitsu K; Nishihara Y; Irie H; Aishima S; Taketomi A; Honda H
    AJR Am J Roentgenol; 2008 Jan; 190(1):W28-34. PubMed ID: 18094269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma.
    Takahashi M; Maruyama H; Ishibashi H; Yoshikawa M; Yokosuka O
    AJR Am J Roentgenol; 2011 Feb; 196(2):W123-31. PubMed ID: 21257852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of hepatocellular carcinoma from non-hepatocellular malignant tumours of liver by chemical-shift MRI at 3 T.
    Ozturk K; Soylu E; Yazici Z; Ozkaya G; Savci G
    Clin Radiol; 2019 Oct; 74(10):797-804. PubMed ID: 31300210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small hepatocellular carcinomas in cirrhosis: differences in contrast enhancement effects between helical CT and MR imaging during multiphasic dynamic imaging.
    Hayashida M; Ito K; Fujita T; Shimizu A; Sasaki K; Tanabe M; Matsunaga N
    Magn Reson Imaging; 2008 Jan; 26(1):65-71. PubMed ID: 17566685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation.
    Tajima T; Honda H; Taguchi K; Asayama Y; Kuroiwa T; Yoshimitsu K; Irie H; Aibe H; Shimada M; Masuda K
    AJR Am J Roentgenol; 2002 Apr; 178(4):885-97. PubMed ID: 11906868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The magnetic resonance and histological correlations in hepatocellular carcinoma].
    Bartolozzi C; Lencioni R; Caramella D; Paolicchi A; Russo R; Romani R
    Radiol Med; 1994; 87(1-2):90-5. PubMed ID: 8128039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MSCT perfusion imaging and its correlation with perfusion parameters, survivin expression, MVD, and pathologic grade in hepatocellular carcinomas].
    Long X; Cao J; Shi L; Li W; Liu H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 34(11):1096-102. PubMed ID: 19952399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCC-to-liver contrast on arterial-dominant phase images of EOB-enhanced MRI: comparison with dynamic CT.
    Kanata N; Yoshikawa T; Ohno Y; Kanda T; Uchida K; Izaki K; Fukumoto T; Ku Y; Itoh T; Kitajima K; Takahashi S; Sugimura K
    Magn Reson Imaging; 2013 Jan; 31(1):17-22. PubMed ID: 22898685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of sequential imaging of hepatocellular carcinoma by contrast-enhanced power Doppler ultrasonograpy.
    Suzuki Y; Fujimoto Y; Hosoki Y; Suzuki M; Sakurai S; Ohhira M; Saito H; Kohgo Y
    Eur J Radiol; 2003 Nov; 48(2):214-9. PubMed ID: 14680917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.
    Kitao A; Zen Y; Matsui O; Gabata T; Kobayashi S; Koda W; Kozaka K; Yoneda N; Yamashita T; Kaneko S; Nakanuma Y
    Radiology; 2010 Sep; 256(3):817-26. PubMed ID: 20663969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadoxetate disodium-enhanced MR imaging: differentiation between early-enhancing non-tumorous lesions and hypervascular hepatocellular carcinomas.
    Goshima S; Kanematsu M; Watanabe H; Kondo H; Mizuno N; Kawada H; Shiratori Y; Onozuka M; Moriyama N; Bae KT
    Eur J Radiol; 2011 Aug; 79(2):e108-12. PubMed ID: 21592707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of early hepatocellular carcinoma and adenomatous hyperplasia (dysplastic nodules) with dynamic ct and a combination of CT and angiography: experience with resected liver specimens.
    Takayasu K; Muramatsu Y; Mizuguchi Y; Moriyama N; Ojima H
    Intervirology; 2004; 47(3-5):199-208. PubMed ID: 15383730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium.
    Hayashi M; Matsui O; Ueda K; Kawamori Y; Kadoya M; Yoshikawa J; Gabata T; Takashima T; Nonomura A; Nakanuma Y
    AJR Am J Roentgenol; 1999 Apr; 172(4):969-76. PubMed ID: 10587130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of primary malignancies of the liver using contrast-enhanced sonography: correlation with pathology.
    Fan ZH; Chen MH; Dai Y; Wang YB; Yan K; Wu W; Yang W; Yin SS
    AJR Am J Roentgenol; 2006 Jun; 186(6):1512-9. PubMed ID: 16714638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double arterial phase dynamic MRI with sensitivity encoding (SENSE) for hypervascular hepatocellular carcinomas.
    Yoshioka H; Takahashi N; Yamaguchi M; Lou D; Saida Y; Itai Y
    J Magn Reson Imaging; 2002 Sep; 16(3):259-66. PubMed ID: 12205581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.